References
- Chiu WT, Yeh KH, Li YC, Gan YH, Chen HY, Hung CC. Traumatic brain injury registry in Taiwan. Neurol. Res. 1997;19(03):261–4.
- Yi YS, Zhi DS. Diagnosis and treatment of traumatic brain injury. Beijing: People’s Health Press; 2000. p1.
- Cadosch D, Gautschi OP, Thyer M, Song S, Skirving AP, Filgueira L, et al.. Humoral factors enhance fracture-healing and callus formation in patients with traumatic brain injury. J Bone Joint Surg Am. 2009;91(2):282–8.
- Toffoli AM, Gautschi OP, Frey SP, Filgueira L, Zellweger R. From brain to bone: evidence for the release of osteogenic humoral factors after traumatic brain injury. Brain Inj. 2008;22(7–8):511–8.
- Frank SJ. Growth hormone, insulin-like growth factor I, and growth: local knowledge. Endocrinology. 2007;148(4):1486–8.
- Shenaq SM, Rabinovsky ED. Gene therapy for plastic and reconstructive surgery. Clin Plast Surg. 1996;23(1):157–71.
- Andrew JG, Hoyland J, Freemont AJ, Marsh D. Insulinlike growth factor gene expression in human fracture callus. Calcif Tissue Int. 1993;53(2):97–102.
- Cernak I, Savic VJ, Lazarov A, Joksimovic M, Markovic S. Neuroendocrine responses following graded traumatic brain injury in male adults. Brain Inj. 1999,13(12):1005–15.
- Murad A, Nath AK, Cha ST, Demir E, Flores-Riveros J, Sierra-Honigmann MR. Leptin is an autocrine/paracrine regulator of wound healing. FASEB J. 2003,17(13):1895–7.
- Carro E, Señaris R, Considine RV, Casanueva FF, Dieguez C. Regulation of in vivo growth hormone secretion by leptin. Endocrinology. 1997;138(5):2203–6.
- Federico G, Baroncelli GI, Vanacore T, Fiore L, Saggese G. Pubertal changes in biochemical markers of growth. Horm Res. 2003;60(Suppl 1):46–51.
- Perkins R, Skirving AP. Callus formation and the rate of healing of femoral fractures in patients with head injuries. J Bone Joint Surg Br. 1987;69(4):521–4.
- Dieter C, Oliver PG. humoral factors enhance fracture-healing and callus formation in patients with traumatic brain injury. J Bone Joint Surg Am. 2009;91:282–8.
- Dieguez C, Vazquez MJ, Romero A, Lopez M, Nogueiras R Hypothalamic control of lipid metabolism: focus on leptin, ghrelin and melanocortins. Neuroendocrinology. 2011;94:1–11.
- Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–32.
- Rosenbaum M, Leibel RL. Leptin: a molecule integrating somatic energy stores, energy expenditure and fertility. Trends Endocrinol Metab. 1998;9:117–23.
- Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, et al.. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone min-eralization. J Bone Miner Res. 2001;16:1426–33.
- Burguera B, Hofbauer LC, Thomas T, Gori F, Evans GL, Khosla S, et al.. leptin reduces ovariectomy-induced bone loss in rats. Endocrinology. 2001;142:3546–53.
- Kakuma T, Wang ZW, Pan W, Unger RH, Zhou YT. Role of leptin in peroxisome proliferator-activated receptor gamma coactivator-1 expression. Endocrinology. 2000;141(12):4576–82.
- Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H, Swick AG. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept. 2000;92:73–8.
- Hamrick MW, Pennington C, Newton D, Xie D, Isales C. Leptin deficiency produces eontrasting phenotypes in bones of the limb and spine. Bone. 2004;34(3):376–83.
- Tena-Sempere M, Manna PR, Zhang FP, Pinilla L, González LC, Diéguez C, et al.. Molecular mechanisms of leptin action in adult rat testis: potential targets for leptin-induced inhibition of steroidogenesis and pattern of leptin receptor messenger ribonucleic acid expression. J Endocrinol. 2001;170(2):413–23.
- Iwaniec UT, Boghossian S, Lapke PD, Turner RT, Kalra SP. Central leptin gene therapy corrects skeletal abnormalities in leptin-deficient ob/ob mice. Peptides. 2007;28:1012–9.
- Bartell SM, Rayalam S, Ambati S, Gaddam DR, Hartzell DL, Hamrick M, et al.. Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice. J Bone Miner Res. 2011;26(8):1710–20.
- Włodarski K, Włodarski P. Leptin as a modulator of osteogenesis. Ortop Traumatol Rehabil. 2009;11(1):1–6.
- Takeda S. [Control of bone metabolism by central nervous system]. Clin Calcium. 2011;21(5):691–6. Japanese.
- Andreasen TT, Oxlund H. Local anabolic effects of growth hormone on intact bone and healing fractures in rats. Calcif Tissue Int. 2003;73:258–64.
- Raschke M, Rasmussen MH, Govender S, Segal D, Suntum M, Christiansen JS. Effects of growth hormone in patients with tibial fracture: a randomized, double-blind, placebo-controlled clinical trial. Eur J Endocrinol. 2007;156:341–51.
- Takahashi MO, Takahashi Y, Iida K, Okimura Y, Kaji H, Abe H, et al.. Growth hormone stimulates tyrosine phosphorylation of focal adhesion kinase [p125( FAK)] and actin stress fiber formation in human osteoblast-like cells, Saos2. Biochem Biophys Res Commun. 1999;263:100–6.
- Hedström M, Sääf M, Brosjö E, Hurtig C, Sjöberg K, Wesslau A, et al.. Positive effects of short-term growth hormone treatment on lean body mass and BMC after a hip fracture: a double-blind placebo-controlled pilot study in 20 patients. Acta Orthop Scand. 2004;75:394–401.